Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Innocan Pharma Corp C.INNO

Alternate Symbol(s):  INNPF

Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. To achieve this aim, the Company developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of... see more

Recent & Breaking News (CSE:INNO)

Innocan Pharma Announces Mackie Research's Institutional Sales Group Issues Enterprise Publication on the Company

Newsfile June 22, 2020

InnoCan Signs Letter of Intent with Tamar to Distribute and Supply CBD "API" for use in InnoCan's Research Projects

Newsfile June 17, 2020

Innocan Pharma Announces Closing of $5.1 Million Prospectus Offering of Units

Newsfile June 10, 2020

InnoCan Pharma Announced the Commencement of its Derma CBD Line Commercial Production in Portugal

Newsfile June 5, 2020

Innocan Pharma Amends Terms of Marketed Short Form Prospectus Offering of Units

Newsfile June 2, 2020

Innocan Pharma Announces Patent Application for Novel Cannabis-Based Psoriasis Treatment

Newsfile May 28, 2020

InnoCan Pharma Enters into Letter of Intent to Develop and Produce Exosomes for Use in its CBD-Loaded Exosome (CLX) Treatments

Newsfile May 22, 2020

Innocan Pharma Announces Pricing of Marketed Short Form Prospectus Offering of Units

Newsfile May 14, 2020

RETRANSMISSION: Innocan Pharma Announces up to $10 Million Public Offering of Units

Newsfile May 12, 2020

Innocan Pharma Announces up to $10 Million Public Offering of Units

Newsfile May 11, 2020

InnoCan Announces Appointment of Professor Daniel Offen, Scientific Advisory Director

Newsfile May 1, 2020

InnoCan to Develop a New Lines of CBD Products for Tamar Technologies

Newsfile April 28, 2020

InnoCan Pharma Collaborates with Tel Aviv University to Develop a New Revolutionary Approach to Treat the COVID-19 Corona Virus with Exosomes-Loaded CBD

Newsfile April 17, 2020

InnoCan Provides Update and Summary About Its Corporate Progress as Its First Products Prepare to Enter the Commercial Marketplace

Newsfile February 11, 2020

InnoCan Pharma Announces Patent Application for Novel Hemorrhoid Treatment

Newsfile February 5, 2020

InnoCan Signs its First Distribution Agreement with "Active Therapeutics" for InnoCan's CBD Derma Cosmetics products in the United Kingdom and Ireland

ACCESS Newswire January 28, 2020

InnoCan Announces Appointment of Prominent Healthcare Executive, Peter Bloch as a Director

ACCESS Newswire January 23, 2020

InnoCan Announces Successful Research Study Advancing Its Development of Cannabidiol Targeted Injection Delivery Platform

ACCESS Newswire January 13, 2020

InnoCan Reports Q3 Financial Results and Business Update

ACCESS Newswire November 29, 2019

InnoCan Signs Agreement to Manufacture Products in the U.S.

ACCESS Newswire November 18, 2019